5th Circuit’s Mifepristone Stay Triggers SCOTUS Emergency InterventionMay 29, 2026Legal NewsA unanimous 5th Circuit panel reinstated in-person mifepristone rules nationwide on May 1, overriding the Trump administration's position before SCOTUS stepped in four days later.
Supreme Court Stays Fifth Circuit Order, Preserves Mifepristone Telehealth AccessMay 29, 2026Legal NewsThe Supreme Court stayed a Fifth Circuit order that had reinstated in-person mifepristone dispensing rules, preserving telehealth access while litigation continues below.
Supreme Court Stays Fifth Circuit Order Restoring Mifepristone In-Person RequirementMay 22, 2026Legal NewsThe Supreme Court stayed the Fifth Circuit's May 1 order reimposing in-person mifepristone rules, preserving telehealth access nationwide while appeals proceed. Thomas and Alito dissented.
Supreme Court Freezes 5th Circuit Order Blocking Mail-Order MifepristoneMay 22, 2026Legal NewsThe Supreme Court indefinitely froze a 5th Circuit ruling that would have ended mail-order mifepristone access, as Alito and Thomas dissented and the Comstock Act emerged as a new front.
Supreme Court Blocks Fifth Circuit Order Restricting Mail-Order Mifepristone AccessMay 15, 2026Legal NewsThe Supreme Court stayed a Fifth Circuit ruling that would have banned mail-order mifepristone, with seven justices granting relief and Alito dissenting in sharp terms.
Fifth Circuit Blocks Mifepristone Mail Access, Drugmakers Rush to Supreme CourtMay 14, 2026Legal NewsThe Fifth Circuit ordered the FDA to reinstate in-person dispensing rules for mifepristone, blocking mail and telehealth access nationally. Drugmakers filed emergency Supreme Court applications.
Fifth Circuit Blocks Mifepristone Telehealth Access; Supreme Court IntervenesMay 14, 2026Legal NewsA Fifth Circuit panel reinstated mifepristone's in-person dispensing rule nationwide; Justice Alito issued successive emergency stays as the full Supreme Court deliberated.
5th Circuit Orders FDA to Reinstate Mifepristone In-Person RequirementMay 6, 2026Law and PolicyThe Fifth Circuit ordered the FDA to reinstate in-person mifepristone dispensing on May 1, 2026; the Supreme Court stayed the ruling three days later.